FIELD: pharmaceuticals.
SUBSTANCE: present invention provides chemical synthesis, anti-tumor and anti-metastatic effects of a double-action conjugate presented by formula I.
EFFECT: synthesis of the conjugate of formula I is carried out by a combination of solid-phase and liquid-phase synthesis, and said conjugate can be used for producing antineoplastic drugs, which is confirmed by reliable results of biological studies.
22 cl, 37 dwg, 13 tbl, 43 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHEMICAL SYNTHESIS AND ANTICANCER AND ANTIMETASTATIC EFFECTS OF DUAL FUNCTIONAL CONJUGATE | 2011 |
|
RU2604718C2 |
| AGENT FOR INHIBITING THE HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME BASED ON PENTAFURANOSYL NUCLEOSIDE DERIVATIVES | 2019 |
|
RU2748103C1 |
| PEPTIDE COMPOUND CAPABLE OF BINDING WITH PSMA, METHOD FOR PRODUCTION AND USE THEREOF | 2021 |
|
RU2823164C2 |
| PD-L1 ANTAGONIST COMPOUND | 2020 |
|
RU2823231C1 |
| COMPOUNDS FOR TREATING CANCER | 2011 |
|
RU2609018C2 |
| CXCR7 ANTAGONISTS | 2013 |
|
RU2649004C2 |
| THIAZOLACTAM COMPOUNDS AS ERK INHIBITORS AND THEIR APPLICATIONS | 2020 |
|
RU2805569C1 |
| FIVE-MEMBERED HETEROCYCLIC PYRIDINE COMPOUNDS AND PREPARATION METHOD AND USE THEREOF | 2014 |
|
RU2668074C2 |
| SPIRO COMPOUNDS AS ERK INHIBITORS AND THEIR USE | 2020 |
|
RU2800042C1 |
| BENZAMIDE DERIVATIVES HAVING ANTICANCER ACTIVITY, METHODS FOR PRODUCTION THEREOF AND USE THEREOF | 2011 |
|
RU2565079C2 |
